arXiv subjects

Geert Litjens

Publications and source records attributed to Geert Litjens.

At least 19 recordsLinked to original sources

arXiv2026

Explainable Artificial Intelligence (XAI) in Computational Pathology: Definitions, Taxonomy, and Recommendations

Computational pathology (CompPath) is transforming medicine by leveraging artificial intelligence (AI) algorithms to support diagnosis, prognosis, and treatment prediction from gigapixel whole-slide images. Clinical adoption is progressing, but is constrained by concerns about safety, accountability, and regulatory oversight in high-stakes clinical environments. Explainable AI (XAI) systems hold promise for building trust and enabling verification, yet the literature remains fragmented due to inconsistent terminology, overlapping methodological families, ad hoc validation, and current reviews. This review aims to formalize XAI methods in CompPath through the: i) introduction of a pathology-centric vocabulary comprising seven core terms; ii) development of a taxonomy across methodological families and three orthogonal axes (stage, type, scope); and iii) establishment of a task-driven framework that maps five clinical questions to recommended methods, method evaluation, and deployment context. Five key gaps between current XAI capabilities and clinical deployment are identified, and actionable steps are proposed to advance XAI for CompPath.

cs.AI↗

arXiv2026

CHIMERA Challenge: Biochemical Recurrence Prediction in Prostate Cancer Patients using multimodal datasets

Biochemical recurrence (BCR), defined as any detectable prostate-specific antigen level after prostatectomy with confirmatory elevation, is widely used as a surrogate endpoint and typically assessed using clinical and pathological variables. Currently, no standardized benchmark exists for multimodal prognostic modeling in urological cancers, partly because curating heterogeneous multimodal data remains challenging. We developed the CHIMERA Challenge, a multimodal benchmark integrating preoperative mpMRI, post-prostatectomy histopathology, patient characteristics, and clinician-derived variables from 267 patients across two institutions. The dataset comprises 801 MRI sequences, 13 clinical variables per case, and 942 WSIs. Training (n=95), validation (n=23), and test (n=149) splits were established and hosted on the Grand Challenge platform. Baseline clinical and pathological characteristics did not differ significantly across splits. Models were evaluated on predicting time to BCR using the C-index. Post-challenge analyses tested how each model type performed when clinician-derived variables were withheld or randomized. Unimodal clinical models achieved the highest test C-index of 0.7402 but proved sensitive to the integrity of these variables, with performance collapsing toward chance (C approximately 0.50) when they were randomized. Multimodal models retained near-baseline performance when these variables were withheld (delta C at most 0.04), indicating their ability to recover prognostic signal directly from imaging data. CHIMERA is the first public, standardized multimodal benchmark for prostate cancer prognosis. Although models using only patient characteristics and clinician-derived variables yielded the highest leaderboard performance, multimodal models demonstrated greater robustness in clinically realistic scenarios where complete expert annotation is not guaranteed.

eess.IV↗

arXiv2026

A Distributional Robustness Margin For Pathology Foundation Models

Pathology foundation models encode non-biological variation introduced by tissue preparation, staining and scanning, enabling shortcut learning that undermines generalisation across institutions. The Robustness Index (RI) was proposed to assess whether local representation geometry is dominated by biological or non-biological variation. However, its construction suffers from structural limitations that make cross-model comparison unreliable, calling for a more principled metric. We introduce the Cross-confounder Robustness Margin (CRoMa), a signed, per-sample margin that measures whether samples sharing the same biology but different confounder lie closer than samples sharing the same confounder but different biology. It is defined for every sample, allowing models to be compared on the same cohort and robustness to be analysed as a distribution rather than reduced to a single pooled score. We evaluated CRoMa across 20 tile-level encoders on three benchmarks. Rankings by median CRoMa were highly consistent across benchmarks (Spearman rho ~ 0.90), yet every encoder retained confounder-dominated samples, whose prevalence and severity varied markedly. Similar patterns emerged for four slide-level encoders evaluated on a separate benchmark, extending the analysis beyond tile-level representations. Higher median CRoMa was associated with smaller shortcut-induced performance losses in downstream linear probes, supporting its use as a representation-level indicator of shortcut susceptibility.

cs.CV↗

arXiv2026

Democratising Pathology Co-Pilots: An Open Pipeline and Dataset for Whole-Slide Vision-Language Modelling

Vision-language models (VLMs) have the potential to become co-pilots for pathologists. However, most VLMs either focus on small regions of interest within whole-slide images, provide only static slide-level outputs, or rely on data that is not publicly available, limiting reproducibility. Furthermore, training data containing WSIs paired with detailed clinical reports is scarce, restricting progress toward transparent and generalisable VLMs. We address these limitations with three main contributions. First, we introduce Polysome, a standardised tool for synthetic instruction generation. Second, we apply Polysome to the public HISTAI dataset, generating HISTAI-Instruct, a large whole-slide instruction tuning dataset spanning 24,259 slides and over 1.1 million instruction-response pairs. Finally, we use HISTAI-Instruct to train ANTONI-α, a VLM capable of visual-question answering (VQA). We show that ANTONI-α outperforms MedGemma on WSI-level VQA tasks of tissue identification, neoplasm detection, and differential diagnosis. We also compare the performance of multiple incarnations of ANTONI-α trained with different amounts of data. All methods, data, and code are publicly available.

cs.CV↗

arXiv2026

Deep Learning From Routine Histology Improves Risk Stratification for Biochemical Recurrence in Prostate Cancer

Accurate prediction of biochemical recurrence (BCR) after radical prostatectomy is critical for guiding adjuvant treatment and surveillance decisions in prostate cancer. However, existing clinicopathological risk models reduce complex morphology to relatively coarse descriptors, leaving substantial prognostic information embedded in routine histopathology underexplored. We present a deep learning-based biomarker that predicts continuous, patient-specific risk of BCR directly from H&E-stained whole-slide prostatectomy specimens. Trained end-to-end on time-to-event outcomes and evaluated across four independent international cohorts, our model demonstrates robust generalization across institutions and patient populations. When integrated with the CAPRA-S clinical risk score, the deep learning risk score consistently improved discrimination for BCR, increasing concordance indices from 0.725-0.772 to 0.749-0.788 across cohorts. To support clinical interpretability, outcome-grounded analyses revealed subtle histomorphological patterns associated with recurrence risk that are not captured by conventional clinicopathological risk scores. This multicohort study demonstrates that deep learning applied to routine prostate histopathology can deliver reproducible and clinically generalizable biomarkers that augment postoperative risk stratification, with potential to support personalized management of prostate cancer in real-world clinical settings.

cs.CV↗

arXiv2026

Computational Pathology in the Era of Emerging Foundation and Agentic AI -- International Expert Perspectives on Clinical Integration and Translational Readiness

Recent breakthroughs in artificial intelligence through foundation models and agents have accelerated the evolution of computational pathology. Demonstrated performance gains reported across academia in benchmarking datasets in predictive tasks such as diagnosis, prognosis, and treatment response have ignited substantial enthusiasm for clinical application. Despite this development momentum, real world adoption has lagged, as implementation faces economic, technical, and administrative challenges. Beyond existing discussions of technical architectures and comparative performance, this review considers how these emerging AI systems can be responsibly integrated into medical practice by connecting deployable clinical relevance with downstream analytical capabilities and their technical maturity, operational readiness, and economic and regulatory context. Drawing on perspectives from an international group, we provide a practical assessment of current capabilities and barriers to adoption in patient care settings.

cs.CE↗

arXiv2026

Designing UNICORN: a Unified Benchmark for Imaging in Computational Pathology, Radiology, and Natural Language

Medical foundation models show promise to learn broadly generalizable features from large, diverse datasets. This could be the base for reliable cross-modality generalization and rapid adaptation to new, task-specific goals, with only a few task-specific examples. Yet, evidence for this is limited by the lack of public, standardized, and reproducible evaluation frameworks, as existing public benchmarks are often fragmented across task-, organ-, or modality-specific settings, limiting assessment of cross-task generalization. We introduce UNICORN, a public benchmark designed to systematically evaluate medical foundation models under a unified protocol. To isolate representation quality, we built the benchmark on a novel two-step framework that decouples model inference from task-specific evaluation based on standardized few-shot adaptation. As a central design choice, we constructed indirectly accessible sequestered test sets derived from clinically relevant cohorts, along with standardized evaluation code and a submission interface on an open benchmarking platform. Performance is aggregated into a single UNICORN Score, a new metric that we introduce to support direct comparison of foundation models across diverse medical domains, modalities, and task types. The UNICORN test dataset includes data from more than 2,400 patients, including over 3,700 vision cases and over 2,400 clinical reports collected from 17 institutions across eight countries. The benchmark spans eight anatomical regions and four imaging modalities. Both task-specific and aggregated leaderboards enable accessible, standardized, and reproducible evaluation. By standardizing multi-task, multi-modality assessment, UNICORN establishes a foundation for reproducible benchmarking of medical foundation models. Data, baseline methods, and the evaluation platform are publicly available via unicorn.grand-challenge.org.

cs.CV↗

arXiv2025

Self-supervised large-scale kidney abnormality detection in drug safety assessment studies

Kidney abnormality detection is required for all preclinical drug development. It involves a time-consuming and costly examination of hundreds to thousands of whole-slide images per drug safety study, most of which are normal, to detect any subtle changes indicating toxic effects. In this study, we present the first large-scale self-supervised abnormality detection model for kidney toxicologic pathology, spanning drug safety assessment studies from 158 compounds. We explore the complexity of kidney abnormality detection on this scale using features extracted from the UNI foundation model (FM) and show that a simple k-nearest neighbor classifier on these features performs at chance, demonstrating that the FM-generated features alone are insufficient for detecting abnormalities. We then demonstrate that a self-supervised method applied to the same features can achieve better-than-chance performance, with an area under the receiver operating characteristic curve of 0.62 and a negative predictive value of 89%. With further development, such a model can be used to rule out normal slides in drug safety assessment studies, reducing the costs and time associated with drug development.

cs.CV↗

arXiv2025

Prototype-Based Multiple Instance Learning for Gigapixel Whole Slide Image Classification

Multiple Instance Learning (MIL) methods have succeeded remarkably in histopathology whole slide image (WSI) analysis. However, most MIL models only offer attention-based explanations that do not faithfully capture the model's decision mechanism and do not allow human-model interaction. To address these limitations, we introduce ProtoMIL, an inherently interpretable MIL model for WSI analysis that offers user-friendly explanations and supports human intervention. Our approach employs a sparse autoencoder to discover human-interpretable concepts from the image feature space, which are then used to train ProtoMIL. The model represents predictions as linear combinations of concepts, making the decision process transparent. Furthermore, ProtoMIL allows users to perform model interventions by altering the input concepts. Experiments on two widely used pathology datasets demonstrate that ProtoMIL achieves a classification performance comparable to state-of-the-art MIL models while offering intuitively understandable explanations. Moreover, we demonstrate that our method can eliminate reliance on diagnostically irrelevant information via human intervention, guiding the model toward being right for the right reason. Code will be publicly available at https://github.com/ss-sun/ProtoMIL.

cs.CV↗

arXiv2025

Label-free Concept Based Multiple Instance Learning for Gigapixel Histopathology

Multiple Instance Learning (MIL) methods allow for gigapixel Whole-Slide Image (WSI) analysis with only slide-level annotations. Interpretability is crucial for safely deploying such algorithms in high-stakes medical domains. Traditional MIL methods offer explanations by highlighting salient regions. However, such spatial heatmaps provide limited insights for end users. To address this, we propose a novel inherently interpretable WSI-classification approach that uses human-understandable pathology concepts to generate explanations. Our proposed Concept MIL model leverages recent advances in vision-language models to directly predict pathology concepts based on image features. The model's predictions are obtained through a linear combination of the concepts identified on the top-K patches of a WSI, enabling inherent explanations by tracing each concept's influence on the prediction. In contrast to traditional concept-based interpretable models, our approach eliminates the need for costly human annotations by leveraging the vision-language model. We validate our method on two widely used pathology datasets: Camelyon16 and PANDA. On both datasets, Concept MIL achieves AUC and accuracy scores over 0.9, putting it on par with state-of-the-art models. We further find that 87.1\% (Camelyon16) and 85.3\% (PANDA) of the top 20 patches fall within the tumor region. A user study shows that the concepts identified by our model align with the concepts used by pathologists, making it a promising strategy for human-interpretable WSI classification.

cs.CV↗

arXiv2024

Navigating the landscape of multimodal AI in medicine: a scoping review on technical challenges and clinical applications

Recent technological advances in healthcare have led to unprecedented growth in patient data quantity and diversity. While artificial intelligence (AI) models have shown promising results in analyzing individual data modalities, there is increasing recognition that models integrating multiple complementary data sources, so-called multimodal AI, could enhance clinical decision-making. This scoping review examines the landscape of deep learning-based multimodal AI applications across the medical domain, analyzing 432 papers published between 2018 and 2024. We provide an extensive overview of multimodal AI development across different medical disciplines, examining various architectural approaches, fusion strategies, and common application areas. Our analysis reveals that multimodal AI models consistently outperform their unimodal counterparts, with an average improvement of 6.2 percentage points in AUC. However, several challenges persist, including cross-departmental coordination, heterogeneous data characteristics, and incomplete datasets. We critically assess the technical and practical challenges in developing multimodal AI systems and discuss potential strategies for their clinical implementation, including a brief overview of commercially available multimodal AI models for clinical decision-making. Additionally, we identify key factors driving multimodal AI development and propose recommendations to accelerate the field's maturation. This review provides researchers and clinicians with a thorough understanding of the current state, challenges, and future directions of multimodal AI in medicine.

cs.AI↗

arXiv2024

Medical diffusion on a budget: Textual Inversion for medical image generation

Diffusion models for text-to-image generation, known for their efficiency, accessibility, and quality, have gained popularity. While inference with these systems on consumer-grade GPUs is increasingly feasible, training from scratch requires large captioned datasets and significant computational resources. In medical image generation, the limited availability of large, publicly accessible datasets with text reports poses challenges due to legal and ethical concerns. This work shows that adapting pre-trained Stable Diffusion models to medical imaging modalities is achievable by training text embeddings using Textual Inversion. In this study, we experimented with small medical datasets (100 samples each from three modalities) and trained within hours to generate diagnostically accurate images, as judged by an expert radiologist. Experiments with Textual Inversion training and inference parameters reveal the necessity of larger embeddings and more examples in the medical domain. Classification experiments show an increase in diagnostic accuracy (AUC) for detecting prostate cancer on MRI, from 0.78 to 0.80. Further experiments demonstrate embedding flexibility through disease interpolation, combining pathologies, and inpainting for precise disease appearance control. The trained embeddings are compact (less than 1 MB), enabling easy data sharing with reduced privacy concerns.

cs.CV↗

arXiv2024

Masked Attention as a Mechanism for Improving Interpretability of Vision Transformers

Vision Transformers are at the heart of the current surge of interest in foundation models for histopathology. They process images by breaking them into smaller patches following a regular grid, regardless of their content. Yet, not all parts of an image are equally relevant for its understanding. This is particularly true in computational pathology where background is completely non-informative and may introduce artefacts that could mislead predictions. To address this issue, we propose a novel method that explicitly masks background in Vision Transformers' attention mechanism. This ensures tokens corresponding to background patches do not contribute to the final image representation, thereby improving model robustness and interpretability. We validate our approach using prostate cancer grading from whole-slide images as a case study. Our results demonstrate that it achieves comparable performance with plain self-attention while providing more accurate and clinically meaningful attention heatmaps.

cs.CV↗

arXiv2024

Understanding metric-related pitfalls in image analysis validation

Validation metrics are key for the reliable tracking of scientific progress and for bridging the current chasm between artificial intelligence (AI) research and its translation into practice. However, increasing evidence shows that particularly in image analysis, metrics are often chosen inadequately in relation to the underlying research problem. This could be attributed to a lack of accessibility of metric-related knowledge: While taking into account the individual strengths, weaknesses, and limitations of validation metrics is a critical prerequisite to making educated choices, the relevant knowledge is currently scattered and poorly accessible to individual researchers. Based on a multi-stage Delphi process conducted by a multidisciplinary expert consortium as well as extensive community feedback, the present work provides the first reliable and comprehensive common point of access to information on pitfalls related to validation metrics in image analysis. Focusing on biomedical image analysis but with the potential of transfer to other fields, the addressed pitfalls generalize across application domains and are categorized according to a newly created, domain-agnostic taxonomy. To facilitate comprehension, illustrations and specific examples accompany each pitfall. As a structured body of information accessible to researchers of all levels of expertise, this work enhances global comprehension of a key topic in image analysis validation.

cs.CV↗

arXiv2024

Metrics reloaded: Recommendations for image analysis validation

Increasing evidence shows that flaws in machine learning (ML) algorithm validation are an underestimated global problem. Particularly in automatic biomedical image analysis, chosen performance metrics often do not reflect the domain interest, thus failing to adequately measure scientific progress and hindering translation of ML techniques into practice. To overcome this, our large international expert consortium created Metrics Reloaded, a comprehensive framework guiding researchers in the problem-aware selection of metrics. Following the convergence of ML methodology across application domains, Metrics Reloaded fosters the convergence of validation methodology. The framework was developed in a multi-stage Delphi process and is based on the novel concept of a problem fingerprint - a structured representation of the given problem that captures all aspects that are relevant for metric selection, from the domain interest to the properties of the target structure(s), data set and algorithm output. Based on the problem fingerprint, users are guided through the process of choosing and applying appropriate validation metrics while being made aware of potential pitfalls. Metrics Reloaded targets image analysis problems that can be interpreted as a classification task at image, object or pixel level, namely image-level classification, object detection, semantic segmentation, and instance segmentation tasks. To improve the user experience, we implemented the framework in the Metrics Reloaded online tool, which also provides a point of access to explore weaknesses, strengths and specific recommendations for the most common validation metrics. The broad applicability of our framework across domains is demonstrated by an instantiation for various biological and medical image analysis use cases.

cs.CV↗

arXiv2024

Uncertainty-guided annotation enhances segmentation with the human-in-the-loop

Deep learning algorithms, often critiqued for their 'black box' nature, traditionally fall short in providing the necessary transparency for trusted clinical use. This challenge is particularly evident when such models are deployed in local hospitals, encountering out-of-domain distributions due to varying imaging techniques and patient-specific pathologies. Yet, this limitation offers a unique avenue for continual learning. The Uncertainty-Guided Annotation (UGA) framework introduces a human-in-the-loop approach, enabling AI to convey its uncertainties to clinicians, effectively acting as an automated quality control mechanism. UGA eases this interaction by quantifying uncertainty at the pixel level, thereby revealing the model's limitations and opening the door for clinician-guided corrections. We evaluated UGA on the Camelyon dataset for lymph node metastasis segmentation which revealed that UGA improved the Dice coefficient (DC), from 0.66 to 0.76 by adding 5 patches, and further to 0.84 with 10 patches. To foster broader application and community contribution, we have made our code accessible at

cs.CV↗

arXiv2023

Hierarchical Vision Transformers for Context-Aware Prostate Cancer Grading in Whole Slide Images

Vision Transformers (ViTs) have ushered in a new era in computer vision, showcasing unparalleled performance in many challenging tasks. However, their practical deployment in computational pathology has largely been constrained by the sheer size of whole slide images (WSIs), which result in lengthy input sequences. Transformers faced a similar limitation when applied to long documents, and Hierarchical Transformers were introduced to circumvent it. Given the analogous challenge with WSIs and their inherent hierarchical structure, Hierarchical Vision Transformers (H-ViTs) emerge as a promising solution in computational pathology. This work delves into the capabilities of H-ViTs, evaluating their efficiency for prostate cancer grading in WSIs. Our results show that they achieve competitive performance against existing state-of-the-art solutions.

cs.CV↗

arXiv2023

Common Limitations of Image Processing Metrics: A Picture Story

While the importance of automatic image analysis is continuously increasing, recent meta-research revealed major flaws with respect to algorithm validation. Performance metrics are particularly key for meaningful, objective, and transparent performance assessment and validation of the used automatic algorithms, but relatively little attention has been given to the practical pitfalls when using specific metrics for a given image analysis task. These are typically related to (1) the disregard of inherent metric properties, such as the behaviour in the presence of class imbalance or small target structures, (2) the disregard of inherent data set properties, such as the non-independence of the test cases, and (3) the disregard of the actual biomedical domain interest that the metrics should reflect. This living dynamically document has the purpose to illustrate important limitations of performance metrics commonly applied in the field of image analysis. In this context, it focuses on biomedical image analysis problems that can be phrased as image-level classification, semantic segmentation, instance segmentation, or object detection task. The current version is based on a Delphi process on metrics conducted by an international consortium of image analysis experts from more than 60 institutions worldwide.

eess.IV↗